UBS O'Connor’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-21,039
| Closed | -$429K | – | 315 |
|
|
2024
Q4 | $429K | Sell |
21,039
-9,705
| -32% | -$198K | 0.01% | 279 |
|
|
2024
Q3 | $896K | Sell |
30,744
-773
| -2% | -$22.5K | 0.02% | 290 |
|
|
2024
Q2 | $732K | Buy |
31,517
+6,484
| +26% | +$151K | 0.02% | 331 |
|
|
2024
Q1 | $514K | Sell |
25,033
-9,431
| -27% | -$194K | 0.01% | 327 |
|
|
2023
Q4 | $740K | Sell |
34,464
-24,488
| -42% | -$526K | 0.02% | 297 |
|
|
2023
Q3 | $1.22M | Buy |
58,952
+10,000
| +20% | +$206K | 0.02% | 305 |
|
|
2023
Q2 | $1.44M | Buy |
+48,952
| New | +$1.44M | 0.03% | 339 |
|
|
2020
Q2 | – | Sell |
-37,200
| Closed | -$651K | – | 310 |
|
|
2020
Q1 | $651K | Buy |
+37,200
| New | +$651K | 0.01% | 227 |
|